AQR Capital Management
ARQT icon

AQR Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

AQR Capital Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Sell
468,253
-31,165
-6% -$795K 0.01% 1294
2025
Q4 		$14.5M Buy
499,418
+58,103
+13% +$1.49M 0.01% 1052
2025
Q3 		$8.32M Buy
441,315
+66,082
+18% +$1.04M 0.01% 1185
2025
Q2 		$5.26M Buy
375,233
+127,037
+51% +$1.78M ﹤0.01% 1264
2025
Q1 		$3.88M Buy
248,196
+43,716
+21% +$616K ﹤0.01% 1254
2024
Q4 		$2.85M Sell
204,480
-47,671
-19% -$522K ﹤0.01% 1339
2024
Q3 		$2.35M Sell
252,151
-5,206
-2% -$51.4K ﹤0.01% 1426
2024
Q2 		$2.39M Buy
257,357
+226,258
+728% +$2.05M ﹤0.01% 1377
2024
Q1 		$308K Sell
31,099
-257,989
-89% -$1.93M ﹤0.01% 2120
2023
Q4 		$934K Buy
+289,088
New +$786K ﹤0.01% 1632

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return